Patient Education

When Trazodone Makes Sleep Worse Before It Makes It Better: The Neurobiological Truth Behind Early Insomnia Rebound

A subset of patients starting trazodone at standard therapeutic doses report a disorienting and counterintuitive experience: their sleep actually deteriorates in the first days or weeks of treatment. Understanding the neurobiological mechanisms behind this paradoxical response can help patients and providers distinguish a manageable adjustment period from a genuine drug-response mismatch—and avoid premature discontinuation of a medication that may ultimately prove beneficial.

Sep 7, 2026

When Trazodone Stops Working at Night: Understanding Sleep Tolerance and What to Do Next

Patients who initially experience dramatic sleep improvements on trazodone sometimes find that those benefits gradually erode over weeks or months—even when the medication continues to support their mood. This phenomenon reflects a neurobiological adaptation specific to trazodone's hypnotic mechanisms, and it is distinct from antidepressant tolerance. Understanding why it happens, and what evidence-supported options exist, can help patients and providers make informed decisions about long-term s

Sep 6, 2026

Stopping Trazodone: What Patients Experience, What Providers Should Know, and How to Do It Safely

Discontinuing trazodone is a clinical decision that deserves the same careful attention as initiating it—yet conversations about stopping are often rushed or absent entirely. Patients may encounter a range of symptoms when stepping down from trazodone, and distinguishing normal physiological adjustment from genuine discontinuation syndrome requires both clinical knowledge and honest communication. This guide provides a practical framework for patients and providers navigating the end of trazodon

Sep 6, 2026

When Your Antidepressant Also Treats Your Pain: Trazodone's Emerging Role in Chronic Pain Management

Most patients prescribed trazodone expect it to address depression or sleep difficulties—but a growing body of clinical evidence suggests the medication may offer meaningful relief for certain chronic pain conditions as well. From fibromyalgia to neuropathic pain, understanding why trazodone works in the pain context requires a closer look at its pharmacological profile and its underappreciated relationship with sleep.

Sep 6, 2026

Why Trazodone May Lose Its Effect Over Time—and What to Do About It

Some patients who have relied on trazodone successfully for months or even years begin to notice that the medication no longer delivers the same relief. This phenomenon—sometimes called tachyphylaxis or treatment plateau—can be disorienting and discouraging. Understanding whether diminishing effects reflect true pharmacological tolerance, disease progression, or other clinical variables is the essential first step toward finding a path forward.

Sep 5, 2026

The Sexual Side Effects of Trazodone: Evidence, Mechanisms, and the Conversations Every Patient Deserves to Have

Sexual dysfunction is among the most underreported—and undertreated—consequences of antidepressant therapy. Trazodone occupies a nuanced position in this conversation, offering a more favorable profile than many alternatives while carrying its own distinct risks. Understanding the clinical evidence empowers patients to have informed, candid discussions with their prescribers.

Sep 5, 2026

50 mg or 400 mg? Understanding Why Trazodone Dosing Looks So Different From Patient to Patient

Trazodone is one of the few psychiatric medications routinely prescribed at doses that differ by a factor of eight depending on the clinical goal. This variability confuses many patients—and occasionally surprises clinicians unfamiliar with its dual-purpose pharmacology. This guide breaks down the science and strategy behind trazodone dosing decisions so patients can have more informed conversations with their healthcare providers.

Sep 5, 2026